Disease Flares Among Early Rheumatoid Arthritis Patients Treated with Continued Methotrexate Either Alone or in Combination with Adalimumab (Humira)

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
van Vollenhoven, Ronald F. [2 ]
Sunkureddi, Prashanth [3 ]
Zhang, Ying [4 ]
Suboticki, Jessica L. [5 ]
Smolen, Josef S. [6 ,7 ]
机构：
[1] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA
[2] Amsterdam Rheumatol & Immunol Ctr ARC, Amsterdam, Netherlands
[3] Univ Texas Med Branch, Galveston, TX 77555 USA
[4] AbbVie Inc, N Chicago, IL USA
[5] AbbVie Inc, Mettawa, IL USA
[6] Med Univ Vienna, Dept Med, Div Rheumatol, Vienna, Austria
[7] Hietzing Hosp, Vienna, Austria
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2456
引用
收藏
页数：2
相关论文
共 50 条
  • [21] DIACEREIN IN COMBINATION WITH METHOTREXATE VERSUS METHOTREXATE ALONE IN THE TREATMENT OF EARLY RHEUMATOID ARTHRITIS
    Louthrenoo, W.
    Nilganuwong, S.
    Nanagara, R.
    Siripaitoon, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 262 - 262
  • [22] Major clinical response and sustained remission over 4 years in patients with rheumatoid arthritis treated with adalimumab (Humira®) plus methotrexate
    Emery, P
    Schiff, MH
    Kalden, JR
    Spencer-Green, GT
    Segurado, OG
    RHEUMATOLOGY, 2005, 44 : I25 - I25
  • [23] The armada trial:: Sustained efficacy after dose reduction of concomitant methotrexate and/or corticosteroids in patients with rheumatoid arthritis treated with adalimumab (HUMIRA®)
    Weinblatt, ME
    Keystone, EC
    Furst, DE
    Kavanaugh, AF
    Spencer-Green, GT
    Segurado, OG
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 436 - 436
  • [24] Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate
    Smolen, Josef S.
    van Vollenhoven, Ronald F.
    Florentinus, Stefan
    Chen, Su
    Suboticki, Jessica L.
    Kavanaugh, Arthur
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (11) : 1566 - 1572
  • [25] Multiple Switching Between the Biosimilar Adalimumab PF-06410293 (Abrilada™) and Reference Adalimumab (Humira®)in Combination with Methotrexate in Patients with Moderately to Severely Active Rheumatoid Arthritis
    Fleischmann, Roy
    Lakhanpal, Sharad
    Saikali, Wassim
    Alvarez, Daniel
    Cox, Donna S.
    Ianos, Claudia
    Wang, Karen
    Zhang, Wuyan
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3145 - 3147
  • [26] METHOTREXATE DOSE HAS MINIMAL EFFECTS ON METHOTREXATE-RELATED TOXICITY IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS TREATED IN COMBINATION WITH ADALIMUMAB - RESULTS OF CONCERTO TRIAL
    Burmester, G.
    Kivitz, A. J.
    van Vollenhoven, R. F.
    Florentinus, S.
    Karunaratne, P. M.
    Kupper, H.
    Dougados, M.
    Fleischmann, R. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 246 - 246
  • [27] METHOTREXATE DOSE HAS MINIMAL EFFECT ON METHOTREXATE-RELATED TOXICITY IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS TREATED IN COMBINATION WITH ADALIMUMAB: RESULTS OF CONCERTO TRIAL
    Burmester, Gerd
    Kivitz, Alan
    van Vollenhoven, Ronald F.
    Florentinus, Stefan
    Karunaratne, Piyalal M.
    Kupper, Hartmut
    Dougados, Maxime
    Fleischmann, Roy
    RHEUMATOLOGY, 2014, 53 : 90 - 91
  • [28] DISCONNECT BETWEEN DISEASE ACTIVITY AND JOINT SPACE NARROWING FOR PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH ADALIMUMAB PLUS METHOTREXATE BUT NOT FOR PATIENTS TREATED WITH METHOTREXATE ALONE
    Landewe, R.
    Ritchlin, C.
    Olds, M.
    Guerette, B.
    Lavie, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : 625 - 626
  • [29] DISCONNECT BETWEEN DISEASE ACTIVITY AND JOINT SPACE NARROWING FOR PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH ADALIMUMAB PLUS METHOTREXATE BUT NOT FOR PATIENTS TREATED WITH METHOTREXATE ALONE
    Landewe, Robert
    Ritchlin, Christopher
    Olds, Michele
    Guerette, Benoit
    Lavie, Frederic
    RHEUMATOLOGY, 2011, 50 : 141 - 141
  • [30] Adalimumab (HUMIRA®) is as effective when used in combination with other DMARDs as with methotrexate in treating rheumatoid arthritis:: The ReAct study.
    Mariette, XL
    Bijlsma, JWJ
    Herold, M
    Eiselstein, J
    Spencer-Green, GT
    Kupper, H
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S183 - S183
12345